Trials / Completed
CompletedNCT00598585
Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
Phase 4 Study of the Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With Chronic Fatigue Syndrome.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Charles Drew University of Medicine and Science · Academic / Other
- Sex
- All
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
Use of Viagra to Alter Symptoms in Patients with Chronic Fatigue Syndrome (CFS)
Detailed description
Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients with Chronic Fatigue Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil (Viagra) | 25 mg tid of either Sildenafil(Viagra) for first week. 50 mg tid of either Sildenafil (Viagra) for second week. 100 mg tid of either Sildenafil (Viagra) 3rd,4th, 5th and 6th week of study participation. |
| DRUG | Placebo | Placebo pills 3X/day for 6 weeks |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2008-01-22
- Last updated
- 2017-06-27
- Results posted
- 2017-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00598585. Inclusion in this directory is not an endorsement.